Clinical Trial Update: Interrupters of VAscular daMAge in Malignant Hypertension

View source ↗

Summary

Centre Hospitalier de Pau reports a completed clinical trial examining interrupters of vascular damage in malignant hypertension. The trial status is COMPLETED …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Hypertension

Snippet

Sponsor: Centre Hospitalier de PAU | Conditions: Malignant Hypertension | Status: COMPLETED